ARS Pharmaceuticals

(NASDAQ) SPRY

Current Price$8.60

Market Cap$796.41M

Since IPO (2022)+41%

5 Year-73%

1 Year-53%

1 Month+0%

ARS Pharmaceuticals Financials at a Glance

Market Cap

$796.41M

Revenue (TTM)

$98.99M

Net Income (TTM)

-$197.98M

EPS (TTM)

-$2.00

P/E Ratio

-4.01

Dividend

$0.00

Beta (Volatility)

1.15 (Average)

Dividend

$0.00

Beta (Volatility)

1.15 (Average)

Price

$8.60

Volume

243,697

Open

$8.05

Price

$8.60

Volume

243,697

Open

$8.05

Previous Close

$8.60

Daily Range

$8.05 - $8.96

52-Week Range

$6.66 - $18.90

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

1.15 (Average)

Price

$8.60

Volume

243,697

Open

$8.05

Previous Close

$8.60

Daily Range

$8.05 - $8.96

52-Week Range

$6.66 - $18.90

Estimated Earnings Date

Aug 12, 2026

SPRY News

ARS Pharma Sales Jump 3,040% in Q2

Motley Fool Markets TeamAug 13, 2025

Young patient with doctor at appointment

Why Shares of ARS Pharmaceuticals Are Plummeting on Wednesday

James HalleySep 20, 2023

SPRY: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ARS Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

163

CEO

Richard E. Lowenthal, MBA

Website

www.ars-pharma.com

Headquarters

San Diego, CA 92130, US

SPRY Financials

Key Financial Metrics (TTM)

Gross Margin

77.10%

Operating Margin

-204.49%

Net Income Margin

-200.00%

Return on Equity

-153.61%

Return on Capital

-85.20%

Return on Assets

-68.84%

Earnings Yield

-24.94%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$796.41M

Shares Outstanding

99.30M

Volume

243.70K

Avg. Volume

1.76M

Financials (TTM)

Gross Profit

$76.32M

Operating Income

-$202.42M

EBITDA

-$192.17M

Operating Cash Flow

-$175.07M

Capital Expenditure

-$248.00K

Free Cash Flow

-$175.32M

Cash & ST Invst.

$200.97M

Total Debt

$96.52M

ARS Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$22.68M

+184.5%

Gross Profit

$16.40M

+317.5%

Gross Margin

72.29%

N/A

Market Cap

$796.41M

N/A

Market Cap/Employee

$5.14M

N/A

Employees

155

N/A

Net Income

-$60.62M

-78.6%

EBITDA

-$57.78M

-71.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$200.97M

-27.1%

Total Debt

$96.52M

+132121.9%

Accounts Receivable

$29.46M

+186.8%

Inventory

$8.82M

+21.3%

Long Term Debt

$96.52M

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-68.84%

N/A

Return on Invested Capital

-85.06%

N/A

Free Cash Flow

-$44.95M

-10.1%

Operating Cash Flow

-$44.95M

-10.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ABUSArbutus Biopharma Corp

ABUSArbutus Biopharma Corp$4.58+3.85%

KURAKura Oncology, Inc.

KURAKura Oncology, Inc.$10.90+5.21%

PROKProKidney Corp.

PROKProKidney Corp.$1.83+7.65%

RZLTRezolute, Inc.

RZLTRezolute, Inc.$5.04+0.20%

SVRASavara Inc.

SVRASavara Inc.$5.90-2.16%

LENZLENZ Therapeutics, Inc.

LENZLENZ Therapeutics, Inc.$5.82+5.63%

PVLAPalvella Therapeutics, Inc.

PVLAPalvella Therapeutics, Inc.$148.21+8.82%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$153.23+0.00%

ONDSOndas

ONDSOndas$7.83+0.02%

HLHecla Mining

HLHecla Mining$15.54+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

TAT&T

TAT&T$22.72+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.83-0.04%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.31+0.05%

Questions About SPRY

What is the current price of ARS Pharmaceuticals?

ARS Pharmaceuticals is trading at $8.60 per share.

What is the 52-week range for ARS Pharmaceuticals?

Over the past 52 weeks, ARS Pharmaceuticals has traded between $6.66 and $18.90.

How much debt does ARS Pharmaceuticals have?

As of the most recent reporting period, ARS Pharmaceuticals reported total debt of $96.52M.

How much cash does ARS Pharmaceuticals have on hand?

ARS Pharmaceuticals reported $24.32M in cash and cash equivalents in its most recent financial results.

What is ARS Pharmaceuticals’s dividend yield?

ARS Pharmaceuticals does not currently have a dividend yield.

ARS Pharmaceuticals

ARS Pharmaceuticals Financials at a Glance

SPRY News

ARS Pharma Sales Jump 3,040% in Q2

Why Shares of ARS Pharmaceuticals Are Plummeting on Wednesday

SPRY: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ARS Pharmaceuticals

SPRY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ARS Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SPRY

What is the current price of ARS Pharmaceuticals?

What is the 52-week range for ARS Pharmaceuticals?

How much debt does ARS Pharmaceuticals have?

How much cash does ARS Pharmaceuticals have on hand?

What is ARS Pharmaceuticals’s dividend yield?

Premium Investing Services